1983
DOI: 10.1007/bf00433016
|View full text |Cite
|
Sign up to set email alerts
|

Effects of chlorpromazine and promazine on the visual aftereffects of tilt and movement

Abstract: The effects of chlorpromazine (CPZ) and promazine on the visual aftereffects of tilt and motion were measured. CPZ markedly reduced the strength of both aftereffects, while promazine produced a smaller and not always significant reduction. Control experiments suggested that the effects were produced in the central visual system rather than by several possible peripheral artefacts or by drowsiness. The effects are discussed with reference to the pharmacological activity of the drugs and their influence on the s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
0

Year Published

1986
1986
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(11 citation statements)
references
References 45 publications
0
11
0
Order By: Relevance
“…Adaptation at the cellular level is plausibly modulated by these systems (McCormick and Williamson, 1989). Indeed, healthy observers administered antipsychotic medications experience a reduction in the aftereffect strength related to tilt, motion, and color (Harris et al, 1986;Harris et al, 1983; but see Janke and Debus, 1972;Lehmann and Csank, 1957). These findings cannot be accounted for by drug effects on retinal blurring, perceived luminance of the adapter, drowsiness, blinking, or loss of fixation (Harris et al, 1986;Harris et al, 1983).…”
Section: Critical Review Of Findings In Schizophreniamentioning
confidence: 99%
See 1 more Smart Citation
“…Adaptation at the cellular level is plausibly modulated by these systems (McCormick and Williamson, 1989). Indeed, healthy observers administered antipsychotic medications experience a reduction in the aftereffect strength related to tilt, motion, and color (Harris et al, 1986;Harris et al, 1983; but see Janke and Debus, 1972;Lehmann and Csank, 1957). These findings cannot be accounted for by drug effects on retinal blurring, perceived luminance of the adapter, drowsiness, blinking, or loss of fixation (Harris et al, 1986;Harris et al, 1983).…”
Section: Critical Review Of Findings In Schizophreniamentioning
confidence: 99%
“…Indeed, healthy observers administered antipsychotic medications experience a reduction in the aftereffect strength related to tilt, motion, and color (Harris et al, 1986;Harris et al, 1983; but see Janke and Debus, 1972;Lehmann and Csank, 1957). These findings cannot be accounted for by drug effects on retinal blurring, perceived luminance of the adapter, drowsiness, blinking, or loss of fixation (Harris et al, 1986;Harris et al, 1983). Studies comparing the effect of antipsychotics with other psychotropic medications suggest that drug effects on aftereffects are primarily due to dopaminergic action.…”
Section: Critical Review Of Findings In Schizophreniamentioning
confidence: 99%
“…Retinal dopamine acting at dopamine receptors contributes to primate orientation processing (Bodis‐Wollner, ), and similar dopamine receptors have been identified in primate and human retina (Zhao et al ., ). Acute cannabis consumption (by means of ∆‐9‐tetrahydrocannabinol) results in a net reduction of retinal dopamine levels (Schlicker et al ., ), which may also decrease tilt magnitude (Harris et al ., ). There is also some evidence that concomitant consumption of cannabis with MDMA may attenuate any residual effects of MDMA on serotonergic function (Morley et al ., , Parrott et al ., ).…”
Section: Possible Confounding Effects Of Other Drugsmentioning
confidence: 99%
“…These include slower aftereffect build-up (Abraham and McCallum, 1973;Claridge, 1960;Herrington and Claridge, 1965), no difference in aftereffect duration (Tress and Kugler, 1979), and reduced aftereffect strength (Kelm, 1962(Kelm, , 1968Wertheimer, 1954;Wertheimer and Jackson, 1957). Discrepant findings across studies have been attributed to a combination of medication use, as antipsychotics reduce visual aftereffect duration in healthy individuals (Harris et al, 1986;Harris et al, 1983), clinical status, and mode of measuring aftereffects (Harris, 1994). A more recent study confirmed slower aftereffect onset in patients with schizophrenia and healthy first-degree relatives, an effect that scaled with positive symptoms in the patient group and the positive dimension of a scale of schizophrenia-like personality traits in the healthy relatives (Surguladze et al, 2012).…”
Section: Introductionmentioning
confidence: 99%